58-34-4 (甲硫噻丙铵,MULTERGAN METHYL SULFATE)

甲硫噻丙铵;

MULTERGAN METHYL SULFATE ;N,N,N-Trimethyl-1-(10H-phenothiazin-10-yl)-2-propanaminium methyl sulfate;THIAZINAMIUM METILSULFATE;(1-(Phenothiazin-10-yl)-2-propyl)trimethylammonium iodide;1-< Pheno-thiazinyl-10'> -Vb;dl-trimethyl[1-methyl-2-(phenothiazin-10-yl)ethyl]ammonium iodide;dl-trimethyl[1-methyl-2-(phenothiazine-10-yl)ethyl]ammonium methyl sulfate;Methylsulfat;Promethazinum-methoiodide;trimethyl-(1-methyl-2-phenothiazin-10-yl-ethyl)-ammonium, iodide;Trimethylammonium-isopropyl-phenthiazin jodid [German];BVIDQAVCCRUFGU-UHFFFAOYSA-M;3354 R.P.;methylpromethazine;Q27280630;DTXSID20871532;Multergan;TRIMETHYL(1-METHYL-2-PHENOTHIAZIN-10-YLETHYL)AMMONIUM METHYL SULPHATE;IA16WBX317;N-(beta-(10-Phenothiazinyl)propyl)trimethylammonium methyl sulfate;Trimethyl (1-methyl-2-phenothiazin-10-ylethyl)ammonium methyl sulfate;SCHEMBL29040;trimethyl[1-methyl-2-(phenothiazine-10-yl)ethyl]ammonium methyl sulfate;THIAZINAMIUM METILSULFATE [WHO-DD];NS00078956;CHEMBL2146061;Metilsulfate de thiazinamium;methyl sulfate;trimethyl(1-phenothiazin-10-ylpropan-2-yl)azanium;Metilsulfate de thiazinamium [INN-French];THIAZINAMIUM METHYLSULFATE [MI];Methylpromethazinium methylsulfuricum;Thiazinamium metilsulfate [INN];Ammonium, trimethyl(1-methyl-2-phenothiazin-10-ylethyl)-, methyl sulfate;Valan;Prothazin methosulfate;Thiazinamium methyl sulfate;Padisal;Thiazinamiummetilsulfat;10H-Phenothiazine-10-ethanaminium, N,N,N,alpha-tetramethyl-, methyl sulfate;58-34-4;Thiazinamium methylsulfate;UNII-IA16WBX317;THIAZINAMIUM METILSULFATE [MART.];Trimethyl(1-methyl-2-(10-phenothiazinyl)ethyl)ammonium methyl sulfate;Thiazinamium metilsulphate;Metilsulfato de tiazinamio [INN-Spanish];Thiazinamii metilsulfas;RP 3554;EINECS 200-376-8;Trimethyl(1-methyl-2-phenothiazin-10-ylethyl)ammonium methyl sulfate;Multezin;Metilsulfato de tiazinamio;Thiazinamii metilsulfas [INN-Latin];N,N,N,alpha-Tetramethyl-10H-phenothiazine-10-ethanaminium methyl sulfate;

BVIDQAVCCRUFGU-UHFFFAOYSA-M

1S/C18H23N2S.CH4O4S/c1-14(20(2,3)4)13-19-15-9-5-7-11-17(15)21-18-12-8-6-10-16(18)19;1-5-6(2,3)4/h5-12,14H,13H2,1-4H3;1H3,(H,2,3,4)/q+1;/p-1

S1C2C=CC=CC=2N(C2C=CC=CC1=2)CC(C)[N+](C)(C)C.S(=O)(=O)([O-])OC

用于制药行业，是一种抗变态反应药物，抗组胺药的原料药。